Prestige® Line of
Equine Vaccines Intervet manufactures a complete
line of quality equine products.
PRESTIGE® V
with HAVLOGEN®
Highly efficacious 5-way protection
for time-saving convenience.
Broad protection against:
Eastern Encephalomyelitis
Western Encephalomyelitis
Rhinopneumonitis Respiratory
(EHV-1 & EHV-4)
Equine Influenza Virus, including
KY 93
Tetanus Toxoid
Formulated to
minimize reactions and maximize protection:
Intervet’s Antigen
Purification System (APSTM) filtration
technology removes extraneous viruses, cellular debris
and foreign protein to reduce post-vaccinal reactions
Precise titration of antigen
levels maintain the critical “antigen mass” to
achieve protective immunity
Low-volume, 1 mL dose
Unique Havlogen® adjuvant:
Intervet’s proprietary
adjuvant technology
Maintains uniform suspension
for consistency and potency – doesn’t
settle out
Stimulates both cell-mediated
(T-cells) and humoral (B-cells) immune responses
Produces a booster effect,
stimulating higher, longer-lasting protection through
the slow release of antigens
DESCRIPTION: A
combination of inactivated, purified, concentrated,
adjuvanted, tissue culture origin, Equine Encephalomyelitis
Virus, Eastern and Western, Equine Herpesvirus EHV-1
and EHV-4, Equine Influenza Virus subtype A2 including
KY 93 strain and Tetanus Toxoid. Intervet serological
data suggest influenza cross protection against certain
U.S. and European strains, including Kentucky 93, 94,
95 and 96, Suffolk 89, Kildare 89 and 92, Austria 92,
Switzerland 93, New Market 1/93 and 2/93, Berlin 94,
Italy 96 and Meath 96.
INDICATIONS:
For vaccination of healthy horses as an aid in the
prevention of Eastern and Western Encephalomyelitis,
Equine Influenza Virus and Tetanus, and as an aid
in the control of respiratory disease caused by Equine
Herpesvirus.
ADMINISTRATION
AND DOSAGE: For primary immunization,
aseptically inject 1 mL intramuscularly and repeat
the dose in 3 to 4 weeks. A 1 mL dose should be
administered annually and at any time epidemic
conditions exist or are reported and exposure is
imminent.
CAUTION: Store
at 35o to 45o F (2o to 7o C). Shake well before using.
Use entire contents when first opened. Do not
vaccinate within 21 days before slaughter. Local
reactions may occur if this product is given subcutaneously.
Inject deep into the muscle only. Anaphylactoid reactions
may occur.
ANTIDOTE: Epinephrine.
Neomycin, polymyxin B, nystatin and thimerosal added as preservatives.
SUPPLIED:
Code: E-995-1 10 x 1 mL (1 dose) sterile syringes per box, individually
printed plastic bag with needle.
E-995-10 10 mL (10 doses) vial.
FOR USE IN ANIMALS
ONLY
*Adjuvant – Intervet’s proprietary technology.